Nuvation Bio Inc. completed the acquisition of AnHeart Therapeutics, issuing shares of Class A Common Stock, Convertible Preferred Stock, and Consideration Warrants.
AI Assistant
NUVATION BIO INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.